Please wait

 

img187228946_0.jpg

 

Firefly Aerospace Announces Second Quarter 2025 Financial Results After Historic IPO

 

Company increased backlog to $1.3 billion by end of July and bolstered balance sheet; FAA cleared Alpha for return to flight

img187228946_1.jpg

Firefly Aerospace rang the Bell at the Nasdaq MarketSite on August 7, 2025.

 

Cedar Park, Texas, September 22, 2025 – Firefly Aerospace (Nasdaq: FLY), a market leading space and defense technology company, today issued financial results for the second quarter ended June 30, 2025.

“Firefly’s historic IPO last month reflects the bold culture of our generational company, which delivers on the most challenging missions in space,” said Firefly Aerospace CEO Jason Kim. “We’re pleased to announce our initial quarterly results as a public company, reflecting the steady progress across our launch and spacecraft products.”

 


 

img187228946_0.jpg

 

Second Quarter 2025 Highlights

CEO Jason Kim testified before Congress on the success of Blue Ghost Mission 1 and the critical future of NASA’s Commercial Lunar Payload Services (CLPS) initiative.
Blue Ghost Mission 2 structures entered assembly in Firefly’s spacecraft cleanroom after completing the Integration Readiness Review, with first payload delivery accepted.
United Arab Emirates’ Rashid 2 Rover announced as an international payload customer on Blue Ghost Mission 2.
Elytra Mission 3 contract awarded by the U.S. Department of Defense’s Defense Innovation Unit for a 2027 national security mission.
Ocula high-resolution imaging service unveiled, providing more than five years of commercial services in lunar orbit via Firefly’s Elytra spacecraft supporting each upcoming Blue Ghost mission.
Sweden signed Technology Safeguards Agreement with the U.S., clearing the way for Alpha launches from Esrange Space Center through Firefly’s partnership with the Swedish Space Corporation.
Northrop Grumman invested $50 million in preferred equity, backing Firefly’s long-term Eclipse™ launch vehicle partnership with additional financial support.

Additional Recent Highlights

Raised $933.1 million in net proceeds from Initial Public Offering of common stock and listed and began trading on the Nasdaq on August 7, 2025.
NASA awarded Blue Ghost Mission 4 contract worth $176.7 million for lunar payload delivery on July 29, 2025, increasing Firefly's total backlog to approximately $1.3 billion.
As of September 22, 2025, reached 95 hot fire tests of the Miranda engine, which will power the debut launch of Eclipse which is expected to take place as early as next year.
FAA issued Return to Flight determination for Alpha on August 26, 2025, with Firefly working to determine the next available launch window for Alpha Flight 7.
NASA awarded $10 million contract addendum on September 22, 2025, for acquisition of additional lunar data collected beyond the initial contractual requirements for Blue Ghost Mission 1.

“We’re ramping our flight cadence and have several Alpha vehicles in production to meet the strong demand for launch services, especially for responsive national security missions and our best-in-class customers,” Kim added.

 


 

img187228946_0.jpg

 

2025 Full-Year Guidance

Firefly expects 2025 full-year revenue to be between $133 million and $145 million.

Conference Call

Firefly will host a conference call today at 4:00 p.m. CT (5:00 p.m. ET) to discuss its second quarter financial results, as well as provide Firefly’s full year outlook.

The live webcast and accompanying presentation, as well as a replay of the webcast, will be available on Firefly’s Investor Relations website: investors.fireflyspace.com.

About Firefly Aerospace

Firefly Aerospace is a space and defense technology company that enables government and commercial customers to launch, land, and operate in space – anywhere, anytime. As the partner of choice for responsive space missions, Firefly is the only commercial company to launch a satellite to orbit with approximately 24-hour notice. Firefly is also the only company to achieve a fully successful landing on the Moon. Established in 2017, Firefly’s engineering, manufacturing, and test facilities are co-located in central Texas to enable rapid innovation. The company’s small- to medium-lift launch vehicles, lunar landers, and orbital vehicles are built with common flight-proven technologies to enable speed, reliability, and cost efficiencies for each mission from low Earth orbit to the Moon and beyond. For more information, visit www.fireflyspace.com. Firefly utilizes its website as a means to distribute material information about the company to the public.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements (including within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended, and Section 27A of the United States Securities Act of 1933, as amended) concerning Firefly. Statements included in this press release that are not statements of historical fact, including statements about our expectations, beliefs, plans, strategies, objectives, prospects, assumptions or future events or performance, are forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “objective,” “ongoing,” “plan,” “predict,” “project,” “potential,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology. In particular, our guidance, outlook and forecasts for full-year 2025, statements about the markets in which we operate, including growth of our various markets, statements about potential new products and product innovation, our ability or expectations to establish new partnerships, our expectations regarding new vehicle launches and launch

 


 

img187228946_0.jpg

 

timelines, and our ability to retain existing customers and maintain their bookings are forward-looking statements. Accordingly, undue reliance should not be placed on such statements.

Various risks that could cause actual results to differ from those expressed by the forward-looking statements included in this press release include, but are not limited to: our failure to manage our growth effectively and our ability to achieve and maintain profitability; the potential for delayed or failed launches, and any failure of our launch vehicles and spacecraft to operate as intended; our inability to manufacture our launch vehicles, landers, or orbital vehicles at a quantity and quality that our customers demand; the hazards and operational risks that our products and service offerings are exposed to, including the wide and unique range of risks due to the unpredictability of space; the market for commercial launch services for small- and medium-sized payloads not achieving the growth potential we expect; our dependence on contracts entered into in the ordinary course of business and our dependence on major customers and vendors; a loss of, or default by, one or more of our major customers, or a material adverse change in any such customer’s business or financial condition, could materially reduce our revenues and backlog; uncertain global macro-economic and political conditions, including the implementation of tariffs; disruptions in U.S. government operations and funding and budgetary priorities of the U.S. government; the failure of our information technology systems, physical or electronic security protections; the inability to operate Alpha at our anticipated launch rate (including due to potential regulatory delays) or finalize the development and delivery of Eclipse; our failure to establish and maintain important relationships with government agencies and prime contractors; the inability to realize our backlog; evolving government laws and regulations; our ability to remediate the material weakness with respect to our internal control over financial reporting and disclosure controls and procedures; our ability to implement and maintain effective internal control over financial reporting in the future; and other factors set forth in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date stated, or if no date is stated, as of the date of this press release. Actual results may vary from the estimates provided. We undertake no intent or obligation to publicly update or revise any of the estimates and other forward-looking statements made in this announcement, whether as a result of new information, future events or otherwise, except as required by law.

 


 

img187228946_0.jpg

 

Use of Non-GAAP Financial Measures

Adjusted EBITDA, Non-GAAP Operating Expenses, Non-GAAP Research and Development, Non-GAAP Selling, General, and Administrative, Non-GAAP Other Expense, and Free Cash Flow are non-GAAP financial measures. These non-GAAP measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with U.S. GAAP. A reconciliation of each non-GAAP financial measure to the most directly comparable financial measure prepared in accordance with U.S. GAAP is included in the supplemental financial data attached to this press release. Non-GAAP financial measures have important limitations as analytical tools and should not be considered in isolation or as a substitute for analyses of Firefly’s performance or cash flows as reported under U.S. GAAP. Non-GAAP financial measures may be defined differently by other companies in our industry and may not be comparable to similarly titled measures of other companies, thereby diminishing their utility.

Firefly believes non-GAAP financial information provides additional insight into the Company’s ongoing performance. Therefore, Firefly provides this information to investors for a more consistent basis of comparison and to help them evaluate the Company’s ongoing performance and liquidity and to enable more meaningful period to period comparisons.

Adjusted EBITDA

We define Adjusted EBITDA as net loss adjusted for interest expense, net, provision for income taxes, depreciation and amortization, stock-based compensation expense, the change in fair value of warrant liabilities, loss on disposal of fixed assets, transaction costs, and other expenses. In addition to net loss, we use Adjusted EBITDA to evaluate our business, measure its performance, and make strategic decisions.

We believe that Adjusted EBITDA provides useful information to management, investors, and analysts in assessing our financial performance and results of operations across reporting periods by excluding items we do not believe are indicative of our core operating performance. Net loss is the U.S. GAAP measure most directly comparable to Adjusted EBITDA. Adjusted EBITDA should not be considered as an alternative to net loss. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

Non-GAAP Operating Expenses

We define Non-GAAP Operating Expenses as operating expenses, less stock-based compensation expense, one-time costs related to the IPO, and loss on disposal of fixed assets. Management believes this non-GAAP measure provides investors with meaningful

 


 

img187228946_0.jpg

 

insight into results from ongoing operations by excluding items of income or loss to present it in accordance with how management manages the business.

Non-GAAP Research and Development

We define Non-GAAP Research and Development as research and development less stock-based compensation expense. Management believes this non-GAAP measure provides investors with meaningful insight into results from ongoing operations by excluding items of income or loss to present it in accordance with how management manages the business.

Non-GAAP Selling, General, and Administrative

We define Non-GAAP Selling, General and Administrative as selling, general and administrative less stock-based compensation expense and one-time costs related to the IPO. Management believes this non-GAAP measure provides investors with meaningful insight into results from ongoing operations by excluding items of income or loss to present it in accordance with how management manages the business.

Non-GAAP Other Expense

We define Non-GAAP Other Expense as other expense less change in fair value of warrant liabilities and certain other items that are not expected to recur in the future. Management believes this non-GAAP measure provides investors with meaningful insight into results from ongoing operations by excluding items of income or loss to present it in accordance with how management manages the business.

Free Cash Flow

We define Free Cash Flow as net cash used in operating activities, less purchases of property and equipment. We believe that Free Cash Flow is a meaningful indicator of liquidity that provides information to management and investors about the amount of cash generated from or used in operations that, after purchases of property and equipment, can be used for strategic initiatives, including continuous investment in our business and strengthening our balance sheet.

Free Cash Flow has limitations as a liquidity measure, and you should not consider it in isolation or as a substitute for analysis of our cash flows as reported under U.S. GAAP. Free Cash Flow may be affected in the near to medium term by the timing of capital investments, fluctuations in our growth and the effect of such fluctuations on working capital, and changes in our cash conversion cycle.

 


 

img187228946_0.jpg

 

Contacts

Media Relations
press@fireflyspace.com

Investor Relations
investors@fireflyspace.com

 


img187228946_2.jpg

CONDENSED CONSOLIDATED STATEMENTS OF NET LOSS AND COMPREHENSIVE LOSS

(unaudited; in thousands, except per share amounts)

 

 

 

For the Three Months
Ended June 30,

 

 

For the Six Months
Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Revenue

 

$

15,549

 

 

$

21,071

 

 

$

71,404

 

 

$

29,388

 

Cost of sales

 

 

11,554

 

 

 

18,120

 

 

 

65,189

 

 

 

28,360

 

Gross profit

 

 

3,995

 

 

 

2,951

 

 

 

6,215

 

 

 

1,028

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

45,774

 

 

 

39,544

 

 

 

93,786

 

 

 

77,179

 

Selling, general, and administrative

 

 

12,571

 

 

 

12,288

 

 

 

25,323

 

 

 

21,868

 

Loss on disposal of fixed assets

 

 

 

 

 

19

 

 

 

 

 

 

22

 

Total operating expenses

 

 

58,345

 

 

 

51,851

 

 

 

119,109

 

 

 

99,069

 

Loss from operations

 

 

(54,350

)

 

 

(48,900

)

 

 

(112,894

)

 

 

(98,041

)

Other expense

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

(5,237

)

 

 

(3,738

)

 

 

(10,401

)

 

 

(7,491

)

Other expense, net

 

 

(4,191

)

 

 

(815

)

 

 

(576

)

 

 

(692

)

Total other expense, net

 

 

(9,428

)

 

 

(4,553

)

 

 

(10,977

)

 

 

(8,183

)

Loss before provision for income taxes

 

$

(63,778

)

 

$

(53,453

)

 

$

(123,871

)

 

$

(106,224

)

Provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

Net loss and comprehensive loss

 

$

(63,778

)

 

$

(53,453

)

 

$

(123,871

)

 

$

(106,224

)

Less: Accretion of dividends of Series C Preferred Stock

 

 

5,363

 

 

 

5,296

 

 

 

10,942

 

 

 

10,515

 

Less: Accretion of dividends of Series D-1 Preferred Stock

 

 

10,856

 

 

 

 

 

 

17,465

 

 

 

 

Less: Accretion of dividends of Series D-3 Preferred Stock

 

 

266

 

 

 

 

 

 

266

 

 

 

 

Net loss available to common stockholders

 

$

(80,263

)

 

$

(58,749

)

 

$

(152,544

)

 

$

(116,739

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per common share

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(5.78

)

 

$

(4.60

)

 

$

(11.17

)

 

$

(9.24

)

Weighted-average common shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

 

13,877

 

 

 

12,765

 

 

 

13,659

 

 

 

12,630

 

 

 


img187228946_2.jpg

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited; in thousands, except per share amounts)

 

 

 

June 30, 2025

 

 

December 31, 2024

 

Assets

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash and cash equivalents

 

$

205,286

 

 

$

123,431

 

Restricted cash, current

 

 

829

 

 

 

424

 

Accounts receivable, net

 

 

5,638

 

 

 

1,004

 

Advanced payments, current

 

 

13,626

 

 

 

52,404

 

Other current assets

 

 

8,730

 

 

 

3,454

 

Total current assets

 

 

234,109

 

 

 

180,717

 

Advanced payments, less current portion

 

 

41,770

 

 

 

41,770

 

Property and equipment, net

 

 

138,654

 

 

 

135,575

 

Restricted cash, less current portion

 

 

15,428

 

 

 

13,703

 

Right-of-use assets - operating leases

 

 

14,366

 

 

 

14,604

 

Right-of-use assets - finance leases

 

 

4,585

 

 

 

3,708

 

Goodwill

 

 

17,097

 

 

 

17,097

 

Other noncurrent assets

 

 

784

 

 

 

158

 

Total assets

 

$

466,793

 

 

$

407,332

 

 

 

 

 

 

 

 

Liabilities, temporary equity, and stockholders' deficit

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Accounts payable

 

$

32,877

 

 

$

37,633

 

Accounts payable - related parties

 

 

441

 

 

 

86

 

Accrued expenses

 

 

16,664

 

 

 

14,419

 

Operating lease liability, current

 

 

316

 

 

 

1,128

 

Finance lease liability, current

 

 

1,067

 

 

 

856

 

Deferred revenue, current

 

 

82,706

 

 

 

108,069

 

Notes payable, current

 

 

6,869

 

 

 

6,349

 

Other current liabilities

 

 

6,495

 

 

 

10,837

 

Total current liabilities

 

 

147,435

 

 

 

179,377

 

Operating lease liability, less current portion

 

 

15,215

 

 

 

16,466

 

Finance lease liability, less current portion

 

 

2,528

 

 

 

1,996

 

Deferred revenue, less current portion

 

 

75,824

 

 

 

45,904

 

Notes payable, less current portion

 

 

123,479

 

 

 

124,079

 

Notes payable, less current portion - related parties

 

 

18,079

 

 

 

17,524

 

Warrant liability

 

 

9,177

 

 

 

4,070

 

Other liabilities, less current portion

 

 

19,681

 

 

 

25,956

 

Total liabilities

 

$

411,418

 

 

$

415,372

 

Commitments and contingencies

 

 

 

 

 

 

Temporary equity

 

 

 

 

 

 

Redeemable convertible preferred stock, $0.0001 par value; 65,408 and 51,033 shares authorized as of June 30, 2025 and December 31, 2024, respectively; 52,543 and 41,588 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively; $1,599,250 and $1,227,158 liquidation preference as of June 30, 2025 and December 31, 2024, respectively

 

 

973,371

 

 

 

759,582

 

Stockholders' deficit

 

 

 

 

 

 

Common stock, $0.0001 par value, 168,772 and 154,397 shares authorized as of June 30, 2025 and December 31, 2024, respectively; 14,008 and 13,241 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively

 

 

2

 

 

 

1

 

Additional paid-in capital, net of issuance costs

 

 

 

 

 

 

Accumulated deficit

 

 

(917,998

)

 

 

(767,623

)

Total stockholders' deficit

 

 

(917,996

)

 

 

(767,622

)

Total liabilities, temporary equity, and stockholders' deficit

 

$

466,793

 

 

$

407,332

 

 

 


img187228946_3.jpg

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited; in thousands)

 

 

 

For the Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

Cash flows from operating activities

 

 

 

 

 

 

Net loss

 

$

(123,871

)

 

$

(106,224

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

7,916

 

 

 

3,037

 

Loss on sale of fixed assets

 

 

 

 

 

22

 

Stock-based compensation

 

 

1,191

 

 

 

834

 

Change in fair value of warrant liability

 

 

5,107

 

 

 

(31

)

Non-cash interest expense

 

 

3,586

 

 

 

4,088

 

Non-cash inventory write-off

 

 

 

 

 

247

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(4,634

)

 

 

(3,660

)

Advanced payments

 

 

38,778

 

 

 

(16,261

)

Other assets

 

 

(4,238

)

 

 

6,303

 

Accounts payable

 

 

(3,344

)

 

 

3,320

 

Accounts payable - related parties

 

 

355

 

 

 

701

 

Accrued expenses

 

 

2,245

 

 

 

119

 

Other liabilities

 

 

(11,190

)

 

 

19,334

 

Right-of-use assets

 

 

986

 

 

 

1,744

 

Lease liabilities

 

 

(2,063

)

 

 

(3,323

)

Deferred revenue

 

 

4,557

 

 

 

8,935

 

Net cash used in operating activities

 

$

(84,619

)

 

$

(80,815

)

Cash flows from investing activities

 

 

 

 

 

 

Purchases of property and equipment

 

 

(11,837

)

 

 

(21,834

)

Net cash used in investing activities

 

$

(11,837

)

 

$

(21,834

)

Cash flows from financing activities

 

 

 

 

 

 

Proceeds from issuance of preferred stock

 

 

184,116

 

 

 

22,186

 

Principal payments on finance leases

 

 

(883

)

 

 

(398

)

Proceeds from notes payable

 

 

 

 

 

24,599

 

Payments on notes payable

 

 

(3,195

)

 

 

(1,008

)

Payments of debt issuance costs

 

 

(575

)

 

 

(2,001

)

Proceeds from repayment of employee note

 

 

383

 

 

 

123

 

Proceeds from exercise of stock options

 

 

595

 

 

 

315

 

Net cash provided by financing activities

 

$

180,441

 

 

$

43,816

 

Net increase (decrease) in cash and cash equivalents and restricted cash

 

$

83,985

 

 

$

(58,833

)

Cash and cash equivalents and restricted cash

 

 

 

 

 

 

Balance, beginning of period

 

 

137,558

 

 

 

95,146

 

Balance, end of period

 

$

221,543

 

 

$

36,313

 

Reconciliation of cash and cash equivalents and restricted cash

 

 

 

 

 

 

Cash and cash equivalents

 

$

205,286

 

 

$

21,865

 

Restricted cash, current

 

 

829

 

 

 

2,470

 

Restricted cash, non-current

 

 

15,428

 

 

 

11,978

 

Total cash and cash equivalents and restricted cash at the end of the period

 

$

221,543

 

 

$

36,313

 

Supplemental disclosures of cash flow information

 

 

 

 

 

 

Cash paid for interest

 

$

11,101

 

 

$

10,666

 

Non-cash investing and financing activities

 

 

 

 

 

 

Property and equipment additions in accounts payable

 

$

1,413

 

 

$

560

 

Capitalized interest (paid-in-kind)

 

$

573

 

 

$

 

Issuance of debt in exchange of software licenses

 

$

664

 

 

$

 

Right-of-use asset acquired in exchange for finance lease liabilities

 

$

1,625

 

 

$

339

 

 

 


img187228946_3.jpg

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

(unaudited; in thousands)

 

The following tables present reconciliations of Adjusted EBITDA, Non-GAAP Research and Development, Non-GAAP Selling, General, and Administrative, Non-GAAP Operating Expenses, Non-GAAP Other Expense, and Free Cash Flow to their most directly comparable financial measures presented in accordance with U.S. GAAP:

 

 

For the Three Months Ended

 

 

For the Six Months Ended

 

 

 

June 30, 2025

 

 

June 30, 2024

 

 

June 30, 2025

 

 

June 30, 2024

 

Net loss

 

$

(63,778

)

 

$

(53,453

)

 

$

(123,871

)

 

$

(106,224

)

Adjusted for:

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

5,237

 

 

 

3,738

 

 

 

10,401

 

 

 

7,491

 

Depreciation and amortization

 

 

3,920

 

 

 

1,541

 

 

 

7,916

 

 

 

3,037

 

Stock-based compensation expense

 

 

760

 

 

 

425

 

 

 

1,191

 

 

 

834

 

Change in fair value of warrant liabilities

 

 

4,191

 

 

 

31

 

 

 

5,107

 

 

 

31

 

Loss on disposal of fixed assets

 

 

 

 

 

19

 

 

 

 

 

 

22

 

One-time costs related to the IPO (1)

 

 

1,767

 

 

 

 

 

 

4,220

 

 

 

 

Other

 

 

 

 

 

8

 

 

 

 

 

 

33

 

Adjusted EBITDA

 

$

(47,903

)

 

$

(47,691

)

 

$

(95,036

)

 

$

(94,776

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Three Months Ended

 

 

For the Six Months Ended

 

 

 

June 30, 2025

 

 

June 30, 2024

 

 

June 30, 2025

 

 

June 30, 2024

 

Research and development

 

$

45,774

 

 

$

39,544

 

 

$

93,786

 

 

$

77,179

 

Stock-based compensation expense

 

 

(177

)

 

 

(118

)

 

 

(295

)

 

 

(242

)

Non-GAAP Research and Development

 

$

45,597

 

 

$

39,426

 

 

$

93,491

 

 

$

76,937

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general, and administrative

 

$

12,571

 

 

$

12,288

 

 

$

25,323

 

 

$

21,868

 

Stock-based compensation expense

 

 

(583

)

 

 

(307

)

 

 

(896

)

 

 

(592

)

One-time costs related to the IPO (1)

 

 

(1,767

)

 

 

 

 

 

(4,220

)

 

 

 

Non-GAAP Selling, General, and Administrative

 

$

10,221

 

 

$

11,981

 

 

$

20,207

 

 

$

21,276

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

$

58,345

 

 

$

51,851

 

 

$

119,109

 

 

$

99,069

 

Stock-based compensation expense

 

 

(760

)

 

 

(425

)

 

 

(1,191

)

 

 

(834

)

One-time costs related to the IPO (1)

 

 

(1,767

)

 

-

 

 

 

(4,220

)

 

 

 

Loss on disposal of fixed assets

 

 

 

 

 

(19

)

 

 

 

 

 

(22

)

Non-GAAP Operating Expenses

 

$

55,818

 

 

$

51,407

 

 

$

113,698

 

 

$

98,213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expense

 

$

9,428

 

 

$

4,553

 

 

$

10,977

 

 

$

8,183

 

Change in fair value of warrant liabilities

 

 

(4,191

)

 

 

(31

)

 

 

(5,107

)

 

 

(31

)

Other

 

 

 

 

 

(8

)

 

 

 

 

 

(33

)

Non-GAAP Other Expense

 

$

5,237

 

 

$

4,514

 

 

$

5,870

 

 

$

8,119

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 (1) Represents costs incurred related to the IPO that do not meet the direct and incremental criteria per SEC Staff Accounting Bulletin Topic 5.A to be charged against the gross proceeds of the transaction, but are not expected to recur in the future.

 

 

 

 

 

For the Three Months Ended

 

 

For the Six Months Ended

 

 

 

June 30, 2025

 

 

June 30, 2024

 

 

June 30, 2025

 

 

June 30, 2024

 

Net cash used in operating activities

 

$

(28,082

)

 

$

(20,232

)

 

$

(84,619

)

 

$

(80,815

)

Purchases of property and equipment

 

 

(9,183

)

 

 

(17,331

)

 

 

(11,837

)

 

 

(21,834

)

Free Cash Flow

 

$

(37,265

)

 

$

(37,563

)

 

$

(96,456

)

 

$

(102,649

)

 

###